ロイタービデオ

次のビジネス (26 ビデオ)

    ビジネス

    GSK says tests hint COVID drug fights Omicron

    Laboratory analysis of the antibody-based COVID-19 therapy GlaxoSmithKline (GSK) is developing with U.S. partner Vir has indicated the drug is effective against the new Omicron variant, the British drugmaker said on Thursday. Conway G. Gittens reports.